In conclusion, endostatin treatment causes the levels of CSLCs in tumor microenvironments to increase, and both aggravated intratumoral hypoxia and attracted cytokine-secreting and growth factor-secreting TAMs, MDSCs and Treg cells in the tumor are related to the increased proportion of CSLCs. This evidence concerns the gene COL18A1 and neoplasm.